| Dr Edward Lee Alexander Iii, MD | |
|
724 S New St, Dover, DE 19904-3540 | |
| (302) 674-4070 | |
| (302) 672-2315 |
| Full Name | Dr Edward Lee Alexander Iii |
|---|---|
| Gender | Male |
| Speciality | Vascular Surgery |
| Experience | 46 Years |
| Location | 724 S New St, Dover, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386638807 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | C10002593 (Delaware) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayhealth Hospital, Kent Campus | Dover, DE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bayhealth Medical Center, Inc | 1658364740 | 288 |
News Archive
University of Liège researchers have demonstrated that the physiological mechanisms triggered during NDE lead to a more vivid perception not only of imagined events in the history of an individual but also of real events which have taken place in their lives!
Alzheimer's disease (AD), which affects an estimated 26 million people worldwide, is the fourth leading cause of death among the elderly and the leading cause of dementia. Predictions are that the number of AD cases will quadruple by 2050.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that are being developed to treat inflammatory diseases, cancer and sexual dysfunction, announced today it has submitted an application to the European Medicines Agency for Orphan Drug Designation for its drug candidate CF102 in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.
With a relatively minor genetic change, a new treatment developed by researchers at the Georgia Institute of Technology and Emory University appears to stop replication of both flu viruses and the virus that causes Covid-19.
› Verified 7 days ago
| Entity Name | Bayhealth Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1285809509 PECOS PAC ID: 1658364740 Enrollment ID: O20081010000398 |
News Archive
University of Liège researchers have demonstrated that the physiological mechanisms triggered during NDE lead to a more vivid perception not only of imagined events in the history of an individual but also of real events which have taken place in their lives!
Alzheimer's disease (AD), which affects an estimated 26 million people worldwide, is the fourth leading cause of death among the elderly and the leading cause of dementia. Predictions are that the number of AD cases will quadruple by 2050.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that are being developed to treat inflammatory diseases, cancer and sexual dysfunction, announced today it has submitted an application to the European Medicines Agency for Orphan Drug Designation for its drug candidate CF102 in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.
With a relatively minor genetic change, a new treatment developed by researchers at the Georgia Institute of Technology and Emory University appears to stop replication of both flu viruses and the virus that causes Covid-19.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Edward Lee Alexander Iii, MD 819 S Governors Ave, Dover, DE 19904-4158 Ph: (302) 674-4070 | Dr Edward Lee Alexander Iii, MD 724 S New St, Dover, DE 19904-3540 Ph: (302) 674-4070 |
News Archive
University of Liège researchers have demonstrated that the physiological mechanisms triggered during NDE lead to a more vivid perception not only of imagined events in the history of an individual but also of real events which have taken place in their lives!
Alzheimer's disease (AD), which affects an estimated 26 million people worldwide, is the fourth leading cause of death among the elderly and the leading cause of dementia. Predictions are that the number of AD cases will quadruple by 2050.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that are being developed to treat inflammatory diseases, cancer and sexual dysfunction, announced today it has submitted an application to the European Medicines Agency for Orphan Drug Designation for its drug candidate CF102 in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.
With a relatively minor genetic change, a new treatment developed by researchers at the Georgia Institute of Technology and Emory University appears to stop replication of both flu viruses and the virus that causes Covid-19.
› Verified 7 days ago
Dr. John F Glenn Iii, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 724 S New St, Dover, DE 19904 Phone: 302-674-4070 Fax: 302-672-2315 | |
Dr. Luiz F Araujo, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 540 S Governors Ave Ste 101a, Dover, DE 19904 Phone: 302-744-7980 Fax: 302-744-7989 | |
Amber Rose Jacobson, Surgery Medicare: Medicare Enrolled Practice Location: 640 South State Street, 3007, Dover, DE 19901 Phone: 302-744-6999 | |
Dr. Assar Ahmed Rather, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 724 S New St, Dover, DE 19904 Phone: 302-674-4070 Fax: 302-672-2315 | |
Dr. David E Schmidt Jr., MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 896 S State St, Dover, DE 19901 Phone: 302-674-4865 Fax: 302-674-4624 | |
Brandt J Feuerstein, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 Banning St, Ste 300, Dover, DE 19904 Phone: 302-735-8850 Fax: 302-735-8851 | |
Dr. Darrell W Carpenter, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 724 S New St, Dover, DE 19904 Phone: 302-674-4070 Fax: 302-672-2315 |